Research
Mixed
Using GLP-1 RAs post-bariatric surgery can enhance weight loss outcomes and prevent weight regain, whereas using them pre-surgery (neoadjuvant) does not improve surgical outcomes and may slightly reduce weight loss.
If you have had bariatric surgery and are experiencing weight regain, adding a GLP-1 RA can help you lose additional weight. However, taking GLP-1 RAs *before* surgery does not improve surgical results and might slightly reduce the amount of weight lost from the surgery itself.
ModerateQualifiesMEDIUM confidence
The combination of bariatric surgery and GLP1RA may enhance weight loss outcomes in patients undergoing bariatric surgery... using GLP1RA prior to surgery as a neoadjuvant did not demonstrate improvements in surgical weight loss, diabetes remission, or bariatric surgery safety.
Why this rating
Based on systematic reviews of observational studies and a few RCTs, but the paper notes limited sample sizes and need for further RCTs.
Source
Bariatric Surgery in the Era of GLP1RA: A Narrative Review
Mathula Muhundan et al. · Advances in Therapy · 2026
DOI 10.1007/s12325-026-03494-7
narrative_review
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Bariatric surgery remains the most efficacious treatment for obesity, producing sustained weight loss of approximately 20% or higher and superior metabolic improvements compared to pharmacotherapy alone.Good
- GLP-1 receptor agonists (GLP-1 RAs) such as semaglutide and tirzepatide can achieve weight loss comparable to sleeve gastrectomy in selected patients, but are limited by real-world factors like cost, tolerability, and adherence.Good
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →